AI Bias Analysis
4 models · Takes ~15 seconds
The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1 billion.
Source
Stat News
Opens original article in a new tab
In this week's Biotech Scorecard newsletter, Adam Feuerstein takes on the company touting gold microdust suspended in water as an ALS treatment.
Legendary cardiologist Eugene Braunwald had two visions for his career. One of them came true.
Scientists are worried that hantaviruses haven’t been as well studied as they ought to be, but not that the MV Hondius cruise ship is ground zero for the next pandemic.
What was lost at the FDA: A year after DOGE’s cuts, six agency staffers describe the work they never thought they’d leave.
